D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $132B
1-Year Est. Return 38.69%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+38.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$132B
AUM Growth
+$7.59B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,643
New
Increased
Reduced
Closed

Top Buys

1 +$1.52B
2 +$1.43B
3 +$798M
4
AMZN icon
Amazon
AMZN
+$646M
5
TXN icon
Texas Instruments
TXN
+$619M

Top Sells

1 +$1.31B
2 +$1.01B
3 +$863M
4
WDC icon
Western Digital
WDC
+$595M
5
META icon
Meta Platforms (Facebook)
META
+$591M

Sector Composition

1 Technology 25.89%
2 Consumer Discretionary 12.56%
3 Healthcare 10.57%
4 Industrials 9.86%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCAX
1926
Bicara Therapeutics
BCAX
$1.24B
$2.3M ﹤0.01%
+136,522
CWAN icon
1927
Clearwater Analytics
CWAN
$6.81B
$2.29M ﹤0.01%
+95,117
BHE icon
1928
Benchmark Electronics
BHE
$1.92B
$2.29M ﹤0.01%
53,585
-30,880
BZH icon
1929
Beazer Homes USA
BZH
$615M
$2.28M ﹤0.01%
112,508
+103,784
EDIT icon
1930
Editas Medicine
EDIT
$248M
$2.27M ﹤0.01%
1,109,590
+993,411
LRN icon
1931
Stride
LRN
$3.57B
$2.27M ﹤0.01%
34,949
-91,948
ALMS
1932
Alumis Inc
ALMS
$3.12B
$2.26M ﹤0.01%
+231,747
IR icon
1933
Ingersoll Rand
IR
$31.8B
$2.26M ﹤0.01%
28,519
+23,966
LAW icon
1934
CS Disco
LAW
$281M
$2.26M ﹤0.01%
290,658
+52,924
PBYI icon
1935
Puma Biotechnology
PBYI
$299M
$2.25M ﹤0.01%
378,296
-120,302
ZNTL icon
1936
Zentalis Pharmaceuticals
ZNTL
$178M
$2.24M ﹤0.01%
1,660,378
+251,575
HLLY icon
1937
Holley
HLLY
$358M
$2.24M ﹤0.01%
542,335
+317,545
PENG
1938
Penguin Solutions Inc
PENG
$934M
$2.24M ﹤0.01%
114,368
+104,150
TGLS icon
1939
Tecnoglass
TGLS
$2B
$2.23M ﹤0.01%
44,403
+6,829
OSW icon
1940
OneSpaWorld
OSW
$2.08B
$2.23M ﹤0.01%
+107,677
GIS icon
1941
General Mills
GIS
$21B
$2.23M ﹤0.01%
48,013
-508,358
EWS icon
1942
iShares MSCI Singapore ETF
EWS
$755M
$2.23M ﹤0.01%
80,905
+11,573
ANRO icon
1943
Alto Neuroscience
ANRO
$691M
$2.22M ﹤0.01%
+124,795
TASK icon
1944
TaskUs
TASK
$935M
$2.22M ﹤0.01%
188,143
-55,516
OKLO
1945
Oklo
OKLO
$9.31B
$2.22M ﹤0.01%
30,901
-320,229
BORR
1946
Borr Drilling
BORR
$1.55B
$2.21M ﹤0.01%
+548,699
WD icon
1947
Walker & Dunlop
WD
$1.57B
$2.21M ﹤0.01%
36,700
+31,800
NAGE
1948
Niagen Bioscience
NAGE
$386M
$2.2M ﹤0.01%
346,545
-199,638
S icon
1949
SentinelOne
S
$4.68B
$2.2M ﹤0.01%
146,929
+61,542
BLZR
1950
Trailblazer Acquisition Corp
BLZR
$345M
$2.2M ﹤0.01%
+220,000